RT Journal Article
SR Electronic
T1 Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit
JF European Respiratory Journal
JO Eur Respir J
FD European Respiratory Society
SP ERJ-00926-2014
DO 10.1183/09031936.00092614
A1 Carlos A. Jiménez-Ruiz
A1 Stefan Andreas
A1 Keir E. Lewis
A1 Philip Tonnesen
A1 C.P. van Schayck
A1 Peter Hajek
A1 Serena Tonstad
A1 Bertrand Dautzenberg
A1 Monica Fletcher
A1 Sarah Masefield
A1 Pippa Powell
A1 Thomas Hering
A1 Stefano Nardini
A1 Thomy Tonia
A1 Christina Gratziou
YR 2015
UL http://erj.ersjournals.com/content/early/2015/04/16/09031936.00092614.abstract
AB Chronic obstructive pulmonary disease (COPD), lung cancer, asthma and pulmonary tuberculosis are common pulmonary diseases that are caused or worsened by tobacco smoking. Growing observational evidence suggests that symptoms and prognosis of these conditions improve upon smoking cessation. Despite increasing numbers of (small) randomised controlled trials suggesting intensive smoking cessation treatments work in people with pulmonary diseases many patients are not given specific advice on the benefits or referred for intensive cessation treatments and, therefore, continue smoking. This is a qualitative review regarding smoking cessation in patients with COPD and other pulmonary disorders, written by a group of European Respiratory Society experts. We describe the epidemiological links between smoking and pulmonary disorders, the evidence for benefits of stopping smoking, how best to assess tobacco dependence and what interventions currently work best to help pulmonary patients quit. Finally, we describe characteristics and management of any “hardcore” smoker who finds it difficult to quit with standard approaches. Smoking cessation is crucial for respiratory patients: every patient must be given advice and help to quit http://ow.ly/ITgsW